Zosyn (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Zosyn drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA],Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| NON-PROPRIETARY NAME: | piperacillin sodium and tazobactam sodium |
| SUBSTANCE NAME: | TAZOBACTAM SODIUM; PIPERACILLIN SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA],Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1993-11-01 |
| END MARKETING DATE: | 0000-00-00 |
Zosyn HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zosyn from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| LABELER NAME: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .25; 2(g/10mL; g/10mL) |
| START MARKETING DATE: | 1993-11-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0206-8852_87c02c02-e11a-45ad-9621-94e95c0b46de |
| PRODUCT NDC: | 0206-8852 |
| APPLICATION NUMBER: | NDA050684 |
Other TAZOBACTAM SODIUM; PIPERACILLIN SODIUM Pharmaceutical Manufacturers / Labelers:
